Considerations regarding the use of nonhuman primates in assessing safety endpoints for pharmaceuticals
Paul C. Brown, Ronald L. Wange
Topics & Concepts
Coronavirus disease 2019 (COVID-19)PandemicExpiration dateMedicineBusinessDrug developmentPublic healthIntensive care medicineDrugPharmacologyRisk analysis (engineering)NursingInfectious disease (medical specialty)Food scienceDiseaseChemistryPathologyBiosimilars and Bioanalytical MethodsComputational Drug Discovery MethodsPharmaceutical studies and practices